SANUWAVE Health, Inc. (SNWV)

NGM – Real vaqt narxi. Valyuta: USD

16.04

+0.04 (0.25%)

Yopilishda: May 12, 2026, 4:00 PM EDT

13.05.2026

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Health Inc. (SNWV) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.66 per share a year ago.

12.05.2026

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Q1 2026 revenues were $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history.

06.05.2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results.

01.05.2026

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

27.03.2026

SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

26.03.2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Q4 2025 revenues were $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record for the Company.

20.03.2026

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 27, 2026, at 8:30 AM (ET) to present its Q4 and Full Year 2025 financial results.

Videolar

No Data

There is no data to display

Press-relizlar

12.05.2026

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Q1 2026 revenues were $9.6 million , up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history.

26.03.2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Q4 2025 revenues were $13.4 million , up 29.7% from Q4 2024. This was an all-time quarterly record for the Company.

09.01.2026

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

08.12.2025

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of its UltraMIST product line to Healogics iSupply.

SANUWAVE Health, Inc. (SNWV)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

SANUWAVE Health, Inc. (SNWV)

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

Videolar

No Data

Press-relizlar

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

Videolar

No Data

Press-relizlar

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Search stocks

SANUWAVE Health, Inc. (SNWV)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

SANUWAVE Health, Inc. (SNWV)

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

Videolar

No Data

Press-relizlar

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

Videolar

No Data

Press-relizlar

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply